Description

Dicloverine Liquid approve as AMBER 2

Antacid and Oxetacaine Oral Suspension. This is an unlicensed medicine approved as AMBER 2 for the treatment of mucositis associated with Systematic Anti-Cancer Therapy (SACT) or radiotherapy.

Ryego- recommended by NICE TA 832 for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age. Approved as AMBER 2.

Ryaltris nasal spray approved as AMBER 2 for the treatment of moderate to severe nasal symptoms associated with allergic rhinitis.

Tacrolimus Modified release tablets (Envarsus) added to the formulary as AMBER 1. All tacrolimus must be prescribed by brand name

Trimbow pMDI 172 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution. Approved as GREEN

GlucoRX dual - Safety needles 5mm approved for use on the formulary as GREEN when use of safety needles is clinically appropriate.

Fuzatal® XL approved as preferred low cost Alfuzosin10mg modified release formulation. Approved as GREEN.

Emeside® 250mg capsules and 250mg/5ml Oral Solution approved as preferred low cost Ethosuximide formulations. Approved as AMBER 2.

Review of formulary recommended food thickeners

Description

Calfovit D3 sachets and Adcal D3 Dissolve (effervescent tablets) have been added to the formulary both classed as GREEN.

Otigo® 40mg/10mg/g ear drop solution approved as GREEN Page 2 AccuChek Guide test strips approved to be used for patients on Medtronic 780G) insulin pump system

Contour Plus test strips and Contour Plus Blue meter approved as an alternative to Contour Next test strips and metre. To be used for those with gestational diabetes.

Description

This guidance is aimed at adults and does not include children under the age of 16 years. Children who require nutritional assessment or intervention should be referred to the Dietetics Service

Description

This bulletin details the Guide on inhaler selection in the management of Asthma approved by PACEF meeting held in May 2022.

Description

Sativex® Oromucosal Spray approved as RED for treatment of moderate to severe spasticity associated with Multiple Sclerosis.

Buprenorphine Long-acting injection Buvidal® –approved as RED for use only by “We are with you” service.

HRT products – temporary removal of formulary restrictions to manage current supply disruption.

Liothyronine Sodium Capsules (ROMA Pharmaceuticals) approved as AMBER 2.

Atorvastatin 4mg/ml liquid (Rosemount Pharmaceuticals) approved as GREEN to be used when standard tablets or chewable tablets are not appropriate.

Mexiletine Hydrochloride hard capsules 50mg,100mg,200mg (Clinigen Healthcare Ltd) approved as AMBER 2 for use for their licensed indication for the treatment of life-threatening ventricular arrhythmias.

Camouflagers (Covermark®, Dermacolor®, Keromask® & Veil®) approved as AMBER 2

NICE TA 773 Empagliflozin for heart failure – Empagliflozin approved as AMBER 2 for this indication.

NICE TA 775 Dapagliflozin for CKD – Dapagliflozin approved as AMBER 2 for this indication.

Description

Solaraze® (Diclofenac)3%Gel changed from amber 2 to GREEN for the treatment of actinic keratosis.

Solacutan® (Diclofenac )3% gel approved as GREEN for the treatment of actinic keratosis.

Efudix® (Fluorouracil )5% cream changed from amber 2 to GREEN on formulary for the treatment of non-malignant skin conditions.

Tirbanibulin (Klisyri®) 10mg/g ointment approved as AMBER 2 for the treatment of actinic keratosis.

Lidocaine plasters 5% approved as AMBER 2 for the management of localised neuropathic pain in patients reviewed by the chronic pain service.

Artificial Salvia review of formulary advice all products classed as GREEN

Semaglutide tablets (Rybelsus®) changed from Amber 2 to green when the use of an oral formulation is indicated.

Sodium cromoglicate 100mg capsules (Nalcrom®) approved as AMBER 2 for unlicensed use for treatment of mast cell disorders

Gonadorelin analogues therapy requested for patients who are under of gender dysphoria services.